ESCRS - PO505 - Light Sensitivity After Covid-19 And Photorefractive Keratectomy

Light Sensitivity After Covid-19 And Photorefractive Keratectomy

Published 2022 - 40th Congress of the ESCRS

Reference: PO505 | Type: ESCRS 2022 - Posters | DOI: 10.82333/krd7-xp87

Authors: Simon Paul Holland* 1 , Geoffrey Ching 1 , David Lin 1 , Niraj Mandal 1 , Amir Bin Ismail 1 , Gregory Moloney 1

1UBC,Vancouver,Canada

Purpose

Post-COVID syndrome manifests in a variety of ways, but light sensitivity has not yet been recognized as part of its symptomatology. This case series identifies nine laser refractive surgery patients with previous SARS-CoV-19 infections who reported severe light sensitivity that persisted for months postoperatively.

Setting

Laser vision clinic in Vancouver

Methods

Retrospective case series

Results

nine patients reported severe LS limiting ability to work that persisted for more than 3 months after  photo refractive surgery. patients with PCR-confirmed COVID-19 infections reported photosensitivity worse in upgaze. All patients recovered after 7 month followup. Where cases were refractory to routine postoperative care, lifitegrast drops then gabapentin PO were trialed in a stepwise escalation of management.

Conclusions

Light sensitivity worse in upgaze that persists for months postoperatively in laser refractive surgery patients with PCR-confirmed COVID-19 is a newly-observed phenomenon. Although meningeal irritation and transient light sensitivity syndrome are in the differential diagnosis for this presentation, a corneal neuralgia-like pathophysiology may be responsible for these presentations.